News

  • 28th February 2025 NEWS

    Patient Organisation Involvement in National and European Health Technology Assessment

    Registration now open! Following on from the positive feedback that we received from participants who attended our inaugural webinar last year, the National Centre for Pharmacoeconomics (NCPE) is once again hosting a webinar for Patient Organisations.  The title is: Patient Organisation Involvement in National and European Health Technology Assessment We […]

  • 7th February 2025 NEWS

    European Commission Opens First Request Period for Joint Scientific Consultations

    The European Commission has launched the first call for medicinal products for Joint Scientific Consultations (JSC) on behalf of the HTACG. JSCs offer HTDs the opportunity to seek advice on the technology from HTA bodies. The HTACG will conduct up to 10 JSCs in 2025 and look to increase capacity […]

  • 11th January 2025 NEWS

    New European legislation for Health Technology Assessment welcomed by the NCPE

    The NCPE has welcomed the introduction of new European legislation for Health Technology Assessment. The EU Health Technology Assessment Regulation (HTAR) comes into effect on January 12, 2025 enabling joint assessments of health technologies (medicinal products and medical devices) across EU Member States. The full statement from the NCPE regarding […]

  • 8th January 2025 NEWS

    Update to the Budget Impact Model Template and NCPE Guideline

    Version 2.1 of the Budget Impact Model was published on 8th of January 2025 and replaces version 2.0. The new version is available here. The NCPE have published the NCPE Budget Impact Guideline. The aim of this guideline is to provide guidance on the conduct of a drug budget impact […]

  • 7th March 2023 NEWS

    Update to Full Submission Template

    Version 3.0 of the Full HTA Submission Template is available here. This template, to be completed by Applicants, outlines the content and format of the written submission to the NCPE as part of a full HTA. For those companies who have already started to prepare a full HTA submission, the […]

  • 29th November 2022 NEWS

    NCPE Head of Strategy appointed as European HTA Coordination group Chair

    Dr. Roisin Adams, NCPE elected as Chair of the Health Technology Assessment Coordination Group. On 28 November 2022, the HTA Coordination Group (HTACG) elected its Chair, Dr. Roisin Adams, National Centre for Pharmacoeconomics, Ireland and co-chairs, Niklas Hedberg Dental and Pharmaceuticals Benefits Agency, Sweden and Marco Marchetti, National Agency for […]

  • 9th August 2022 NEWS

    Update to Submission Templates

    Notice to Applicants: Please refer to updated versions of the RR Submission Template v2.2, Applicant Template v2.1, and the Submission Checklist v1.4 when making submissions. These are available from the Submission Templates section of the website.

  • 7th April 2022 NEWS

    Updated NCPE Rapid Review Applicant Submission Template

    Version 2.1 of the Rapid Review Submission templates includes a requirement to submit the NCPE Budget Impact Model Template for all Rapid Review submissions. Version 2.1 of this template was published on 07 April 2022 and replaces version 2.0. Submissions using the old template (version 2.0) will be accepted until 12 May 2022.

  • 26th November 2021 NEWS

    COVID-19 Evidence Review Group

    Latest Updates…

  • 8th October 2021 NEWS

    Press Release HAG EUNETHTA21

    Press Release HAG EUNETHTA21 – Professor Michael Barry, Director of the National Centre for Pharmacoeconomics joins the inaugural Heads of Agency Group.